Espadilla, Crispina L.
HRN: 23-01-29 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/23/2024
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
03/23/2024
03/30/2024
PO
5ML
TID
ORAL CANDIDIASIS
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes